Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-044259
Filing Date
2025-05-15
Accepted
2025-05-15 16:25:55
Documents
64
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0241456-10q_180life.htm   iXBRL 10-Q 763615
2 CERTIFICATION ea024145601ex31-1_180life.htm EX-31.1 8734
3 CERTIFICATION ea024145601ex31-2_180life.htm EX-31.2 8724
4 CERTIFICATION ea024145601ex32-1_180life.htm EX-32.1 3024
5 CERTIFICATION ea024145601ex32-2_180life.htm EX-32.2 3026
6 GRAPHIC image_001.jpg GRAPHIC 3555
  Complete submission text file 0001213900-25-044259.txt   5250425

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE atnf-20250331.xsd EX-101.SCH 55010
8 XBRL CALCULATION FILE atnf-20250331_cal.xml EX-101.CAL 29234
9 XBRL DEFINITION FILE atnf-20250331_def.xml EX-101.DEF 270853
10 XBRL LABEL FILE atnf-20250331_lab.xml EX-101.LAB 470593
11 XBRL PRESENTATION FILE atnf-20250331_pre.xml EX-101.PRE 274324
66 EXTRACTED XBRL INSTANCE DOCUMENT ea0241456-10q_180life_htm.xml XML 483448
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38105 | Film No.: 25953871
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)